A Phase 1/2/3 Study of TSHA-102 Gene Therapy in Females With Rett Syndrome (REVEAL Pivotal Study)
Clinical trial NCT05606614 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05606614
- Sponsor
- Taysha Gene Therapies, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-06
- Primary completion
- 2031-06-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.